Stock Events

Stock Events

ElectroCore 

$6.03
59
+$0.39+6.91% Tuesday 19:57

Statistics

Day High
6.12
Day Low
5.69
52W High
8.64
52W Low
4.16
Volume
22,008
Avg. Volume
69,355
Mkt Cap
48.22M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.61
-0.51
-0.4
-0.3
Expected EPS
-0.612
Actual EPS
N/A

Financials

-47.2%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
50.36MRevenue
-23.77MNet Income

Analyst Ratings

$18.00Average Price Target
The highest estimate is 18.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ECOR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
LivaNova
LIVN
Mkt Cap2.87B
LivaNova PLC operates in the same space of neuromodulation, providing therapies that could directly compete with ElectroCore's solutions for epilepsy and other neurological conditions.
Inspire Medical Systems
INSP
Mkt Cap2.13B
Inspire Medical Systems, Inc. offers innovative obstructive sleep apnea treatments using nerve stimulation, a direct competitor to ElectroCore's nerve stimulation therapies.
Neogen
NEOG
Mkt Cap1.34B
Neogen Corporation, while primarily focused on food and animal safety, has divisions that explore bioelectronic medicine, potentially overlapping with ElectroCore's market.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation offers a wide range of medical devices, including neuromodulation products that could serve as alternatives to ElectroCore's technology.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc., through its acquisition of Allergan, has entered the neuromodulation market, potentially competing with ElectroCore's offerings.
Medtronic
MDT
Mkt Cap116.33B
Medtronic PLC provides a broad array of medical devices, including those for neuromodulation, directly competing with ElectroCore's nerve stimulation devices.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew plc, while mainly focused on orthopedics, has started exploring the bioelectronic medicine space, which could put it in competition with ElectroCore.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation's medical technologies, including neurotechnology and spine products, could indirectly compete with ElectroCore by offering different solutions for similar conditions.

About

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Show more...
CEO
Dr. Thomas J. Errico M.D.
Employees
73
Country
US
ISIN
US28531P2020

Listings

XNAS
US
ECOR
F
DE
43E0.F
BOATS
BOATS
ECOR.BOATS

0 Comments

Share your thoughts

FAQ

What is ElectroCore stock price today?▼
The current price of ECOR is $6.03 USD — it has increased by +6.91% in the past 24 hours. Watch ElectroCore stock price performance more closely on the chart.
What is ElectroCore stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ElectroCore stocks are traded under the ticker ECOR.
Is ElectroCore stock price growing?▼
ECOR stock has fallen by -9.87% compared to the previous week, the month change is a -20.45% fall, over the last year ElectroCore has showed a -2.58% decrease.
What is ElectroCore market cap?▼
Today ElectroCore has the market capitalization of 48.22M
When is the next ElectroCore earnings date?▼
ElectroCore is going to release the next earnings report on April 30, 2026.
What were ElectroCore earnings last quarter?▼
ECOR earnings for the last quarter are -0.4 USD per share, whereas the estimation was -0.4 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ElectroCore revenue for the last year?▼
ElectroCore revenue for the last year amounts to 50.36M USD.
What is ElectroCore net income for the last year?▼
ECOR net income for the last year is -23.77M USD.
How many employees does ElectroCore have?▼
As of April 01, 2026, the company has 73 employees.
In which sector is ElectroCore located?▼
ElectroCore operates in the Health Care sector.
When did ElectroCore complete a stock split?▼
The last stock split for ElectroCore was on February 15, 2023 with a ratio of 1:15.
Where is ElectroCore headquartered?▼
ElectroCore is headquartered in Rockaway, US.